Skip to main content

How do the costs charged by private GPs compare to NHS general practice?

As I was returning home via my local tube station, I was handed a flyer for a newly established private general practice. I live in a relatively affluent part of London so there may well be demand for private primary care services, particularly as many local NHS general practices are under considerable workload and funding pressures, and are struggling to meet demand. The new private general practice offers individual insurance plans that start ‘from’ £35 per month (£420 per year). For patients without insurance, a one-off 20 minute consultation is £110 and an ECG is £95. A private prescription (excluding cost of medication) is £15. I compared this to my own practice where the entire sum we receive annually for each patient on our list is about £120 (this includes the annual capitation fee plus various other payments such as reimbursement of costs of premises). The average payment per patient to general practices in England is around £136 annually. It made me realise what good value for money our existing NHS services are. Jeremy Hunt may criticise doctors but the bottom line is that we are already providing cost-effective care. There is always more we can do to improve the quality and efficiency of the health services we provide but this requires a collaborative approach between the government and doctors, rather than the very adversarial approach we have seen from the government in recent years.

Comments

Popular posts from this blog

The Hidden Cost of Cheaper NHS Contracts: Losing Community Trust

NHS budgets are under considerable pressure. It is therefore unsurprising that many NHS Integrated Care Boards (ICBs) In England will aim to prioritise price in contract awards, But this approach is a significant threat to community-centred healthcare. While competitive tendering is a legally required, an excessive focus on costs in awarding NHS contracts risks overshadowing key factors such as established community trust, local expertise, and the long-term impact on continuity of care. This shift towards cheaper, often external, commercial providers threatens to cut the links between communities and their local health services. The argument that competitive tendering is solely about legal compliance, and not cost, is undermined by the very nature of such tendering, which by design encourages the lowest bid. This approach risks eroding the social fabric of local healthcare provision, where established relationships and understanding of specific community needs are essential. Establishe...

MPH Student Presentations on the NHS Care.Data Programme

As part of a session on primary care data in the Health Informatics module on the Imperial Master of Public Health Programme, I asked students to work in two groups to present arguments for and against the NHS Care.Data programme. Care.Data is an NHS programme that will extract data from the medical records held by general practitioners (GPs) in England. The Care.Data programme takes advantage of the very high level of use of electronic medical records by GPs in England. After extraction, data will be uploaded to the NHS Health and Social Care Information Centre (HSCIC). The data will then be used for functions such as health care planning, monitoring disease patterns and research. The programme has been controversial with proponents arguing that the programme will bring many benefits for the NHS and the population of England; and opponents arguing it is a major breach of privacy. You can view the two presentations to help inform you further about these arguments: Arguments fo...

Talking to Patients About Weight-Loss Drugs

The use of weight-loss drugs such as GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) has increased rapidly in recent years. These drugs can help some people achieve significant weight reduction, but they are not suitable for everyone and require careful counselling before starting treatment. By discussing benefits, risks, practicalities, and  uncertainties, clinicians can help patients make informed, realistic decisions about their treatment. Key points to discuss with patients 1. Indications and eligibility These drugs are usually licensed for adults with a specific BMI. They should be used alongside lifestyle interventions such as dietary change, increased physical activity, and behaviour modification. 2. Potential side effects – some can be serious Common adverse effects include nausea, vomiting, diarrhoea, and abdominal discomfort. Less common but more serious risks include gallstones, pancreatitis and visual problems. Patients should know what to watch for a...